Naturally occurring T cell mutations enhance engineered T cell therapies-Reference-Cited by-同舟云学术

Naturally occurring T cell mutations enhance engineered T cell therapies

Published:2024-02-07 Issue:7999 Volume:626 Page:626-634
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Garcia Julie,Daniels Jay^ORCID,Lee Yujin^ORCID,Zhu Iowis^ORCID,Cheng Kathleen,Liu Qing,Goodman Daniel^ORCID,Burnett Cassandra,Law Calvin^ORCID,Thienpont Chloë^ORCID,Alavi Josef,Azimi Camillia^ORCID,Montgomery Garrett^ORCID,Roybal Kole T.^ORCID,Choi Jaehyuk^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41586-024-07018-7.pdf

Reference48 articles.

1. Hou, A. J., Chen, L. C. & Chen, Y. Y. Navigating CAR-T cells through the solid-tumour microenvironment. Nat. Rev. Drug Discov. 20, 531–550 (2021).

2. Wang, L. et al. Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes. Nat. Genet. 47, 1426–1434 (2015).

3. Rafiq, S., Hackett, C. S. & Brentjens, R. J. Engineering strategies to overcome the current roadblocks in CAR T cell therapy. Nat. Rev. Clin. Oncol. 17, 147–167 (2020).

4. Larson, R. C. & Maus, M. V. Recent advances and discoveries in the mechanisms and functions of CAR T cells. Nat. Rev. Cancer 21, 145–161 (2021).

5. Mustjoki, S. & Young, N. S. Somatic mutations in “benign” disease. N. Engl. J. Med. 384, 2039–2052 (2021).

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design concept of intelligent integrated control system for neutral beam injection;Plasma Physics and Controlled Fusion;2024-09-03

2. Synthetic Gene Circuits as a Promising Approach in Cancer Immunotherapy;Advances in Medical Diagnosis, Treatment, and Care;2024-08-28

3. Strategies for Improving CAR T Cell Persistence in Solid Tumors;Cancers;2024-08-16

4. Future perspectives on engineered T cells for cancer;Trends in Cancer;2024-08

5. The underlying mechanism of chimeric antigen receptor (CAR)-T cell therapy triggering secondary T-cell cancers: Mystery of the Sphinx?;Cancer Letters;2024-08